Los Angeles Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,979
| Closed | -$730K | – | 1260 |
|
|
2024
Q3 | $730K | Hold |
9,979
| – | – | ﹤0.01% | 751 |
|
|
2024
Q2 | $683K | Sell |
9,979
-6,045
| -38% | -$414K | ﹤0.01% | 773 |
|
|
2024
Q1 | $1.11M | Sell |
16,024
-1,550
| -9% | -$107K | ﹤0.01% | 664 |
|
|
2023
Q4 | $1.26M | Buy |
17,574
+2,210
| +14% | +$158K | ﹤0.01% | 602 |
|
|
2023
Q3 | $800K | Buy |
15,364
+371
| +2% | +$19.3K | ﹤0.01% | 706 |
|
|
2023
Q2 | $949K | Buy |
14,993
+1,368
| +10% | +$86.6K | ﹤0.01% | 667 |
|
|
2023
Q1 | $738K | Sell |
13,625
-1,217
| -8% | -$65.9K | ﹤0.01% | 749 |
|
|
2022
Q4 | $785K | Buy |
14,842
+6,788
| +84% | +$359K | ﹤0.01% | 773 |
|
|
2022
Q3 | $375K | Buy |
+8,054
| New | +$375K | ﹤0.01% | 1008 |
|
|
2021
Q1 | – | Sell |
-9,132
| Closed | -$290K | – | 1664 |
|
|
2020
Q4 | $290K | Buy |
+9,132
| New | +$290K | ﹤0.01% | 1384 |
|
|
2019
Q1 | – | Sell |
-51,030
| Closed | -$581K | – | 1448 |
|
|
2018
Q4 | $581K | Sell |
51,030
-20,875
| -29% | -$238K | ﹤0.01% | 925 |
|
|
2018
Q3 | $1.56M | Sell |
71,905
-27,465
| -28% | -$596K | 0.01% | 735 |
|
|
2018
Q2 | $1.76M | Buy |
+99,370
| New | +$1.76M | 0.01% | 727 |
|
|
2017
Q3 | – | Sell |
-60,720
| Closed | -$754K | – | 1361 |
|
|
2017
Q2 | $754K | Buy |
+60,720
| New | +$754K | ﹤0.01% | 838 |
|